Search Results - "Pan, Xiuyi"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    A novel intronic circular RNA circFGFR1int2 up-regulates FGFR1 by recruiting transcriptional activators P65/FUS and suppressing miR-4687-5p to promote prostate cancer progression by Wang, Ruyue, Zhong, Jinjing, Pan, Xiuyi, Su, Zhengzheng, Xu, Yunyi, Zhang, Mengni, Chen, Xueqin, Chen, Ni, Yu, Ting, Zhou, Qiao

    Published in Journal of translational medicine (22-11-2023)
    “…Abstract Fibroblast growth factor receptor 1 (FGFR1) is a core component of the FGFs/FGFR pathway that activates multiple signalling pathways, including…”
    Get full text
    Journal Article
  5. 5

    circEZH2E2/E3 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression by Su, Zhengzheng, Zhang, Mengni, Luo, Han, Zhong, Jinjing, Tan, Junya, Xu, Yunyi, Pan, Xiuyi, Zeng, Hao, Nie, Ling, Xu, Miao, Chen, Ni, Chen, Xueqin, Zhou, Qiao

    Published in Cancer science (01-04-2023)
    “…The histone methyltransferase enhancer of zeste homolog 2 (EZH2) is overexpressed in a variety of malignancies including prostate cancer (PCa) and may play…”
    Get full text
    Journal Article
  6. 6

    Atypical metanephric adenoma: Shares similar histopathological features and molecular changes of metanephric adenoma and epithelial-predominant Wilms’ tumor by Yin, Xiaoxue, Zhang, Xingming, Pan, Xiuyi, Tan, Junya, Zheng, Linmao, Zhou, Qiao, Chen, Ni

    Published in Frontiers in oncology (14-10-2022)
    “…Background Metanephric adenomas (MAs) are rare, benign renal tumors. Wilms’ tumors (WTs) are malignant embryonic tumors that originated from nephrogenic…”
    Get full text
    Journal Article
  7. 7

    A primary intracranial neuroepithelial neoplasm with novel TCF3::BEND2 fusion: a case report by Zheng, Linmao, Luo, Tao, Xian, Jie, Zhang, Mengxin, Pan, Xiuyi, Wang, Xiang, Yue, Qiang, Zhou, Qiao, Chen, Ni

    Published in Acta neuropathologica communications (11-11-2024)
    “…Astroblastoma, MN1-altered, is a rare circumscribed glial neoplasm that is composed of round, cuboidal, orcolumnar cells with astroblastic perivascular…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    AKR1B10 Is a New Sensitive and Specific Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma by Zheng, Linmao, Zhang, Xingming, Pan, Xiuyi, Huang, Zhuo, Zhang, Mengxin, Xian, Jie, Wei, Yuyan, Nie, Ling, Zhang, Mengni, Gong, Jing, Chen, Xueqin, Zhou, Qiao, Zeng, Hao, Chen, Ni

    Published in Modern pathology (01-11-2023)
    “…Fumarate hydratase (FH)–deficient renal cell carcinoma (RCC) is a rare and distinct subtype of renal cancer caused by FH gene mutations. FH negativity and…”
    Get full text
    Journal Article
  12. 12

    The roles of mutated SPINK1 gene in prostate cancer cells by Pan, Xiuyi, Tan, Junya, Yin, Xiaoxue, Liu, Qianqi, Zheng, Linmao, Su, Zhengzheng, Zhou, Qiao, Chen, Ni

    Published in Mutagenesis (08-12-2022)
    “…SPINK1-positive prostate cancer (PCa) has been identified as an aggressive PCa subtype. However, there is a lack of definite studies to elucidate the…”
    Get full text
    Journal Article
  13. 13

    circEZH2 E2 /E3 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression by Su, Zhengzheng, Zhang, Mengni, Luo, Han, Zhong, Jinjing, Tan, Junya, Xu, Yunyi, Pan, Xiuyi, Zeng, Hao, Nie, Ling, Xu, Miao, Chen, Ni, Chen, Xueqin, Zhou, Qiao

    Published in Cancer science (01-04-2023)
    “…The histone methyltransferase enhancer of zeste homolog 2 (EZH2) is overexpressed in a variety of malignancies including prostate cancer (PCa) and may play…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center by Nie, Ling, Pan, Xiuyi, Zhang, Mengni, Yin, Xiaoxue, Gong, Jing, Chen, Xueqin, Xu, Miao, Zhou, Qiao, Chen, Ni

    Published in The Prostate (01-06-2019)
    “…Background Overexpression of ERG protein resulting from TMPRSS2:ERG rearrangement is highly specific for prostate cancer (PCa). However, the biological…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis by Zhang, Xingming, Shen, Pengfei, He, Qiying, Yin, Xiaoxue, Chen, Zhibin, Gui, Haojun, Shu, Kunpeng, Tang, Qidun, Yang, Yaojing, Pan, Xiuyi, Wang, Jia, Chen, Ni, Zeng, Hao

    Published in Scientific reports (24-03-2016)
    “…All available surgical treatments for benign prostatic hyperplasia (BPH) have their individual advantages or disadvantages. However, the lack of head-to-head…”
    Get full text
    Journal Article
  19. 19
  20. 20

    The expression profile and prognostic value of SPINK1 in initially diagnosed bone metastatic prostate cancer by Pan, Xiuyi, Zhang, Xingming, Gong, Jing, Tan, Junya, Yin, Xiaoxue, Tang, Qidun, Shu, Kunpeng, Shen, Pengfei, Zeng, Hao, Chen, Ni

    Published in The Prostate (01-06-2016)
    “…BACKGROUND SPINK1 has been described to be mutually exclusively expressed in prostate cancer (PCa), but its expression profiles and the probable roles in bone…”
    Get full text
    Journal Article